Erdheim-Chester disease (ECD) is an ultra-rare non-Langerhans cell histiocytosis characterized by CD68-positive, CD1a/S100-negative histiocytes, frequently associated with BRAF V600E and MAPK pathway mutations. This evidence concerns the gene CD68 and Langerhans cell histiocytosis.